Cybin Corp. CEO Discusses Ongoing Efforts to Develop One of the First Commercially Approved Psychedelic Medications for Mental Health

NEXT STORY
Hospital Architecture Market to Exhibit Promising CAGR Driven By Rising Demand Witnessed Worldwide, says Fortune Business Insights
PREV STORY
Syringe Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Syringe Type, Application, Usability, and End User and Geography
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Provectus Biopharmaceuticals Receives Notice of Allowance for Refractory Pediatric Solid Tumor Cancer Monotherapy and Combination Therapy Patent for PV-10® Immunotherapy from United States Patent and Trademark Office

author_avatar
NASDAQ Market News

Kura Oncology Appoints Chief Operating Officer, Expands Clinical Development Team as Company Prepares for First Registration-Directed Trial

– John Farnam appointed to newly created position of Chief Operating Officer – – ...

author_avatar
NASDAQ Market News

Annual Report 2015

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Annual Report ...

author_avatar
NASDAQ Market News